Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023-09 · 21 (9) · 961-979
DOI: 10.6004/jnccn.2023.0045 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-09. Verfasst von David S Ettinger und 42 weiteren Autor:innen. Beteiligte Einrichtung: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Hauptthemen laut MEDLINE: Mesothelioma, Mesothelioma, Malignant. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term “malignant” is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Fred Hutchinson Cancer Center.
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Centerand Cleveland Clinic Taussig Cancer Institute.
- University of Colorado Cancer Center.
- Huntsman Cancer Institute at the University of Utah.
- Fox Chase Cancer Center.
Zitieren
APA
Ettinger, D. S., Wood, D. E., Stevenson, J., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P., …, & Hughes, M. (2023). Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(9), 961-979. https://doi.org/10.6004/jnccn.2023.0045
Vancouver
Ettinger DS, Wood DE, Stevenson J, Aisner DL, Akerley W, Bauman JR, et al. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(9):961-979. doi:10.6004/jnccn.2023.0045
BibTeX
@article{Ettinger2023,
author = {Ettinger, David S and Wood, Douglas E and Stevenson, James and Aisner, Dara L and Akerley, Wallace and Bauman, Jessica R and Bharat, Ankit and Bruno, Debora S and Chang, Joe Y and Chirieac, Lucian R and DeCamp, Malcolm and Dilling, Thomas J and Dowell, Jonathan and Durm, Gregory A and Gettinger, Scott and Grotz, Travis E and Gubens, Matthew A and Hegde, Aparna and Lackner, Rudy P and Lanuti, Michael and Lin, Jules and Loo, Billy W and Lovly, Christine M and Maldonado, Fabien and Massarelli, Erminia and Morgensztern, Daniel and Mullikin, Trey C and Ng, Thomas and Otterson, Gregory A and Patel, Sandip P and Patil, Tejas and Polanco, Patricio M and Riely, Gregory J and Riess, Jonathan and Shapiro, Theresa A and Singh, Aditi P and Tam, Alda and Tanvetyanon, Tawee and Yanagawa, Jane and Yang, Stephen C and Yau, Edwin and Gregory, Kristina M and Hughes, Miranda},
title = {Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {9},
pages = {961--979},
doi = {10.6004/jnccn.2023.0045}
}
EUVIMED